Risk in drug trials

Lancet. 2006 Dec 23;368(9554):2205. doi: 10.1016/S0140-6736(06)69881-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic / adverse effects*
  • Humans
  • Research Design*
  • Risk Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • TGN-1412